Whitney Maxwell to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Whitney Maxwell has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.643
-
Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia. Pharmacotherapy. 2017 Sep; 37(9):1172-1190.
Score: 0.528
-
Implementation of the American Diabetes Association's Standards of Medical Care post-Medicare Part D: The case of statin utilization in the elderly with diabetes. Res Social Adm Pharm. 2016 May-Jun; 12(3):419-27.
Score: 0.115